ABRAXIS ONCOLOGY
Dead / Cancelled — Cancelled — Section 8 (as of 29 Jul 2016)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78865042
- Registration number
- 3730110
- Mark type
- Design + words
- Filed
- 19 Apr 2006
- Published for opposition
- 29 Aug 2006
- Registered
- 22 Dec 2009
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment of cancer; pharmaceuticals, namely, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; nanoparticles for drug delivery or imaging agent delivery sold as an integral component of drugs or imaging agents
Owner
- ABRAXIS BIOSCIENCE, LLC, Summit, NJ, US
- ABRAXIS BIOSCIENCE, LLC, LOS ANGELES, CA, US
- Abraxis BioScience, Inc., Los Angeles, CA, US
- Abraxis BioScience, Inc., Los Angeles, CA, US
Prior registrations
Prosecution history
- 29 Jul 2016 — CANCELLED SEC. 8 (6-YR)
- 25 Jan 2016 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Jan 2016 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Oct 2010 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Oct 2010 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Dec 2009 — REGISTERED-PRINCIPAL REGISTER
- 17 Nov 2009 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 17 Nov 2009 — ASSIGNED TO LIE
- 30 Oct 2009 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Sept 2009 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Sept 2009 — USE AMENDMENT FILED
- 17 Sept 2009 — TEAS STATEMENT OF USE RECEIVED
- 28 May 2009 — SOU EXTENSION 5 GRANTED
- 18 May 2009 — SOU EXTENSION 5 FILED